Vericel Corporation (VCEL) Financials
VCEL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 353.7 million | 127.7 million |
2023-09-30 | 318.1 million | 113.7 million |
2023-06-30 | 310.7 million | 111.8 million |
2023-03-31 | 265.1 million | 71.1 million |
VCEL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 6.8 million | 6.9 million |
2023-09-30 | 600000 | 7.9 million |
2023-06-30 | 6.0 million | 8.8 million |
2023-03-31 | -1.1 million | 8.7 million |
VCEL Net Income
No data available :(
VCEL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 109.6 million | - | 88.0 million |
2023-09-30 | 105.3 million | - | 85.1 million |
2023-06-30 | 97.8 million | - | 83.4 million |
2023-03-31 | 119.3 million | - | 46.9 million |
VCEL Shares Outstanding
VCEL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 7.8 million | 4.9 million | 30.9 million | - |
2023-09-30 | 6.6 million | 5.7 million | 30.0 million | - |
2023-06-30 | 4.2 million | 5.3 million | 30.6 million | - |
2023-03-31 | 8.9 million | 5.2 million | 29.5 million | - |
VCEL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 65.0 million | 16.5 million |
2023-09-30 | 45.6 million | 15.0 million |
2023-06-30 | 45.9 million | 16.0 million |
2023-03-31 | 41.0 million | 14.5 million |
VCEL
Price: $47.83
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.07 USD
P/E Ratio: -218.33
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 122353
Ebitda: -4.7 millionMarket Capitalization: 2.4 billion